Vasoactive intestinal peptide attenuates concanavalin A-mediated liver injury.

Luo, Qingqiong

Vasoactive intestinal peptide attenuates concanavalin A-mediated liver injury. [electronic resource] - European journal of pharmacology Apr 2009 - 226-33 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1879-0712

10.1016/j.ejphar.2009.02.012 doi


Animals
Apoptosis--drug effects
Chemical and Drug Induced Liver Injury--physiopathology
Concanavalin A--toxicity
Cyclic AMP--metabolism
Disease Models, Animal
Gene Expression Regulation
Hepatocytes--drug effects
Interferon-gamma--drug effects
Interleukin-10--metabolism
Liver--drug effects
Male
Mice
Mice, Inbred C57BL
Receptors, Vasoactive Intestinal Polypeptide, Type I--metabolism
Transaminases--drug effects
Tumor Necrosis Factor-alpha--drug effects
Vasoactive Intestinal Peptide--administration & dosage